{"title":"用于大口径动脉通路的塞与缝合血管关闭装置:一项系统综述和荟萃分析:塞与缝合血管关闭装置。","authors":"Anastasios Apostolos MD , Konstantinos Konstantinou MD , Nikolaos Ktenopoulos MD , Vasileios Panoulas PhD","doi":"10.1016/j.amjcard.2025.05.030","DOIUrl":null,"url":null,"abstract":"<div><div>Vascular complications after cardiovascular interventions requiring large-bore arterial access remain frequent and devastating. Whether plug-based vascular closure devices (P-VCD) or sutured-based vascular closure device (S-VCD) are superior in terms of safety and efficacy remains unclear. Aim of our systematic review and meta-analysis was to compare P-VCD with S-VCD. We systematically screened 3 major databases for 2-arm studies comparing P-VCD with S-VCD. Primary endpoint was device success. Secondary endpoints included in-hospital all-cause mortality, major and minor bleeding, major and minor vascular complications, unplanned vascular surgery, endovascular treatment and hospital stay. For categorical variables, we used risk ratios (RRs) with 95% confidence intervals (CIs) and for continuous variables, mean differences or standardized mean differences. A total of 23 studies and 7,584 patients were included in our analysis. No significant differences were observed in device success (RR: 0.98, 95% CI: 0.96 to 1.00, <em>I<sup>2</sup> = 62%</em>), all-cause mortality (RR: 0.60, 95% CI: 0.19 to 1.87), major bleedings (RR: 0.68, 95% CI: 0.44 to 1.07), minor bleedings (RR: 0.83, 95% CI: 0.54 to 1.27), major vascular complications (RR: 0.89, 95% CI: 0.56 to 1.42), minor vascular complication (RR: 1.22, 95% CI: 0.82 to 1.83), endovascular treatment (RR: 1.35, 95% CI: 0.79 to 2.29) or unplanned vascular surgery (RR: 1.12, 95% CI: 0.68 to 1.87). However, hospital length of stay was reduced by 0.2 ± 0.13 days in patients treated with P-VCD. In conclusion, our systematic review and meta-analysis, the largest to date, demonstrated no significant differences between P-VCD and S-VCD, regarding safety or efficacy outcomes, except for a shorter hospital stay associated P-VCD. Further studies are required to validate these results.</div></div>","PeriodicalId":7705,"journal":{"name":"American Journal of Cardiology","volume":"252 ","pages":"Pages 56-66"},"PeriodicalIF":2.3000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Plug- Versus Sutured-Based Vascular Closure Devices for Large Bore Arterial Access: A Systematic Review and Meta-Analysis\",\"authors\":\"Anastasios Apostolos MD , Konstantinos Konstantinou MD , Nikolaos Ktenopoulos MD , Vasileios Panoulas PhD\",\"doi\":\"10.1016/j.amjcard.2025.05.030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Vascular complications after cardiovascular interventions requiring large-bore arterial access remain frequent and devastating. Whether plug-based vascular closure devices (P-VCD) or sutured-based vascular closure device (S-VCD) are superior in terms of safety and efficacy remains unclear. Aim of our systematic review and meta-analysis was to compare P-VCD with S-VCD. We systematically screened 3 major databases for 2-arm studies comparing P-VCD with S-VCD. Primary endpoint was device success. Secondary endpoints included in-hospital all-cause mortality, major and minor bleeding, major and minor vascular complications, unplanned vascular surgery, endovascular treatment and hospital stay. For categorical variables, we used risk ratios (RRs) with 95% confidence intervals (CIs) and for continuous variables, mean differences or standardized mean differences. A total of 23 studies and 7,584 patients were included in our analysis. No significant differences were observed in device success (RR: 0.98, 95% CI: 0.96 to 1.00, <em>I<sup>2</sup> = 62%</em>), all-cause mortality (RR: 0.60, 95% CI: 0.19 to 1.87), major bleedings (RR: 0.68, 95% CI: 0.44 to 1.07), minor bleedings (RR: 0.83, 95% CI: 0.54 to 1.27), major vascular complications (RR: 0.89, 95% CI: 0.56 to 1.42), minor vascular complication (RR: 1.22, 95% CI: 0.82 to 1.83), endovascular treatment (RR: 1.35, 95% CI: 0.79 to 2.29) or unplanned vascular surgery (RR: 1.12, 95% CI: 0.68 to 1.87). However, hospital length of stay was reduced by 0.2 ± 0.13 days in patients treated with P-VCD. In conclusion, our systematic review and meta-analysis, the largest to date, demonstrated no significant differences between P-VCD and S-VCD, regarding safety or efficacy outcomes, except for a shorter hospital stay associated P-VCD. Further studies are required to validate these results.</div></div>\",\"PeriodicalId\":7705,\"journal\":{\"name\":\"American Journal of Cardiology\",\"volume\":\"252 \",\"pages\":\"Pages 56-66\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S000291492500342X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000291492500342X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Plug- Versus Sutured-Based Vascular Closure Devices for Large Bore Arterial Access: A Systematic Review and Meta-Analysis
Vascular complications after cardiovascular interventions requiring large-bore arterial access remain frequent and devastating. Whether plug-based vascular closure devices (P-VCD) or sutured-based vascular closure device (S-VCD) are superior in terms of safety and efficacy remains unclear. Aim of our systematic review and meta-analysis was to compare P-VCD with S-VCD. We systematically screened 3 major databases for 2-arm studies comparing P-VCD with S-VCD. Primary endpoint was device success. Secondary endpoints included in-hospital all-cause mortality, major and minor bleeding, major and minor vascular complications, unplanned vascular surgery, endovascular treatment and hospital stay. For categorical variables, we used risk ratios (RRs) with 95% confidence intervals (CIs) and for continuous variables, mean differences or standardized mean differences. A total of 23 studies and 7,584 patients were included in our analysis. No significant differences were observed in device success (RR: 0.98, 95% CI: 0.96 to 1.00, I2 = 62%), all-cause mortality (RR: 0.60, 95% CI: 0.19 to 1.87), major bleedings (RR: 0.68, 95% CI: 0.44 to 1.07), minor bleedings (RR: 0.83, 95% CI: 0.54 to 1.27), major vascular complications (RR: 0.89, 95% CI: 0.56 to 1.42), minor vascular complication (RR: 1.22, 95% CI: 0.82 to 1.83), endovascular treatment (RR: 1.35, 95% CI: 0.79 to 2.29) or unplanned vascular surgery (RR: 1.12, 95% CI: 0.68 to 1.87). However, hospital length of stay was reduced by 0.2 ± 0.13 days in patients treated with P-VCD. In conclusion, our systematic review and meta-analysis, the largest to date, demonstrated no significant differences between P-VCD and S-VCD, regarding safety or efficacy outcomes, except for a shorter hospital stay associated P-VCD. Further studies are required to validate these results.
期刊介绍:
Published 24 times a year, The American Journal of Cardiology® is an independent journal designed for cardiovascular disease specialists and internists with a subspecialty in cardiology throughout the world. AJC is an independent, scientific, peer-reviewed journal of original articles that focus on the practical, clinical approach to the diagnosis and treatment of cardiovascular disease. AJC has one of the fastest acceptance to publication times in Cardiology. Features report on systemic hypertension, methodology, drugs, pacing, arrhythmia, preventive cardiology, congestive heart failure, valvular heart disease, congenital heart disease, and cardiomyopathy. Also included are editorials, readers'' comments, and symposia.